High intensity focused ultrasound treatment with GnRH - a pretreatment type II uterine fibroids (greater than 4 cm) non randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024663

Enrollment

Unknown

Registered

2019-07-20

Start date

2019-01-01

Completion date

Unknown

Last updated

2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II uterine fibroids (greater than 4 cm)

Interventions

Two groups:high-intensity focused ultrasound versus gnrh-a

Eligibility

Sex/Gender

Female

Age

29 Years to 53 Years

Inclusion criteria

Inclusion criteria: 1. Type B ultrasonic confirmed II > 4 cm in diameter uterine fibroids; 2. Single submucosal myoma; 3. Require treatment and keep the uterus, and do not want to use open or laparoscopic surgery; 4. Can communicate feelings during treatment; 5. Patients' informed consent, complete medical history data and complete follow-up data.

Exclusion criteria

Exclusion criteria: 1. Combined pregnancy; 2. Patients with malignant uterine lesions; 3. Patients with tumors in other parts; 4. Patients with previous blood system diseases or severe organ dysfunction, combined with severe visceral diseases; 5. Patients unable to communicate independently; 6. Contraindications to high-intensity focused ultrasound; 7. Those who are contraindicated to use GnRH-a; 8. Contraindicated hysteroscopic surgery.

Design outcomes

Primary

Measure	Time frame
hemoglobin;Myoma size;UFS-QOL;adverse reactions;	—

Countries

China

Contacts

Public ContactHonggui Zhou

Affiliated Hospital of North Sichuan Medical College

hongguizhou@163.com+86 15983775513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026